A research team from Worcester Polytechnic Institute won a $1.2 million grant from the National Science Foundation to develop a smart phone app for people with advanced diabetes.
The proposed application, currently named "sugar," will link a patient’s smart phone, glucose meter and scale to track and archive blood sugar levels and weight. Patients with foot ulcers will be able to use the phone’s camera to capture and analyze images of the lesions.
"The reality is that nearly all the management of a person’s diabetes is done by the patient, away from a doctor’s office or clinic. So we envision this new application as a way to help these patients achieve better outcomes," Bengisu Tulu, project leader and assistant professor at WPI said in prepared remarks.
Sugar uses algorithms and will prompt patients with specific alerts based on their blood sugar and weight readings over time.
"The application will provide relevant, personalized feedback for the patient that encourages them to make good decisions," said Tulu.
The four-year project will be organized through WPI’s Healthcare Delivery Institute with diabetes specialists at the University of Massachusetts Medical School.
The first two years are slated for technological research and development. If a prototype is developed as planned, the project’s final two years will see clinical trials of the the new application at UMass Medical School.
The company’s website describes the meter as "is the first available blood glucose meter that seamlessly connects to the Apple iPhone and iPod touch for the flexibility to manage your diabetes whenever, wherever."
Sanofi’s device, which connects the AgaMatrix glucose monitoring technology to iPhones and iPods, won CE Mark clearance earlier this year.
Here’s a roundup of other dealflow and investment news:
Early stage life sciences teams win $200k
Early stage life sciences research teams from Lehigh University, Philadelphia University and Thomas Jefferson University won $200,000 each from the QED Proof of Concept program at the University City Science Center. Read more
Health start up raises funds with former Apple CEO
Former Apple CEO John Sculley invested in Salem, N.H.-based health monitoring start up Misfit Wearables Corp. Read more
Tissue Regenix to raise $39M for expansion
Tissue Regenix, the York, England-based regenerative medicine company is set to raise £25 million ($38.8 million) through a conditional share placing to fund its expansion. Read more
Ultrasound company raises $6.6M for stroke device
Redmond, Wash.-based ultrasound company Cerevast Therapeutics landed $6.6 million in venture capital to develop a new ultrasound technology treatment for stroke patients. Read more
ACT enters into settlement agreements
Regenerative medicine company Advanced Cell Technology Inc. will issue 240.5 million shares to 40 holders of warrants and debentures. Read more